Results 151 to 160 of about 16,555,945 (165)
Some of the next articles are maybe not open access.
Evaluation framework for monoclonal B-cell lymphocytosis.
Journal of Clinical Oncologye22571 Background: Monoclonal B cell lymphocytosis (MBL) is recognized as a precursor to chronic lymphocytic leukemia (CLL). There is an ongoing debate over whether MBL represents a benign, senescent condition or warrants further investigation ...
Andrienne Mckenzie, Cheryl Mensah
semanticscholar +1 more source
Development of a novel blood-based translational PCR screen for monoclonal B-cell lymphocytosis.
Journal of Clinical Oncologye19033 Background: Over 10 million Americans have monoclonal B-cell lymphocytosis (MBL), a precursor to CLL, with age-associated increase in frequency, from ~5% at 45 years to >50% in nonagenarians.
Pratik Shah +8 more
semanticscholar +1 more source
International Journal of Laboratory Hematology
Monoclonal B-cell lymphocytosis (MBL) is a type of chronic lymphocytic leukemia (CLL) and offers a unique window into the initial stages of leukemogenesis.
I. Kazmi +8 more
semanticscholar +1 more source
Monoclonal B-cell lymphocytosis (MBL) is a type of chronic lymphocytic leukemia (CLL) and offers a unique window into the initial stages of leukemogenesis.
I. Kazmi +8 more
semanticscholar +1 more source
Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis
Leukemia and Lymphoma, 2007Heather A Leitch +2 more
exaly
CLL-like monoclonal B-cell lymphocytosis: Are we all bound to have it?
Seminars in Cancer Biology, 2010Cristina Scielzo +2 more
exaly
Monoclonal B cell lymphocytosis and “in situ” lymphoma
Seminars in Cancer Biology, 2014Lydia Scarfò, Kennosuke Karube
exaly
Clinical and diagnostic implications of monoclonal B-cell lymphocytosis
Best Practice and Research in Clinical Haematology, 2010Peter Hillmen, Andy C Rawstron
exaly

